NCT05835856

Brief Summary

The study is a multicentre Proof-of-Concept. The general objective of the e-VITA project is to develop a personalized virtual coach capable of interacting with its elderly interlocutor. The experimentation will be carried out in 4 sites: Italy, France, Germany and Japan.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
4 countries

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 28, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

July 24, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

8 months

First QC Date

April 18, 2023

Last Update Submit

October 26, 2023

Conditions

Keywords

virtual coacholder adultstechnological systemquality of lifeusabilitywell-being

Outcome Measures

Primary Outcomes (1)

  • Change in the Quality of Life

    The EQ-5D-5L scale consists of five dimensions: mobility, independence, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems. The participant is asked to indicate his/her health status by ticking the box corresponding to the most appropriate statement in each of the five dimensions. The numbers from the five dimensions can be combined into a 5-digit number that describes the health status of the participant.

    baseline and 6 months later

Secondary Outcomes (8)

  • Change in usability

    At 3 and 6 months from baseline

  • Change in frailty status

    baseline and 6 months later

  • Change in nutritional capacity

    baseline and 6 months later

  • Change in affinity with technology

    baseline and 6 months later

  • Change in cognitive status

    baseline and 6 months later

  • +3 more secondary outcomes

Study Arms (5)

NAO robot group

EXPERIMENTAL
Device: Virtual coach with NAO robot

Google Nest Hub (2e generation) group

EXPERIMENTAL
Device: Virtual coach with Google Nest Hub (2e generation) group

Gatebox group

EXPERIMENTAL
Device: Virtual coach with Gatebox device

CelesTE robot group

EXPERIMENTAL
Device: virtual coach with CelesTE robot

Control group

OTHER
Other: booklet

Interventions

The coaching device used is the softbank NAO 5 and NAO 6 humanoid interactive mobile robot. These robot platform allows multimodal natural language interaction and robot autonomous movement.

NAO robot group

The coaching device used is Google Nest Hub (2e generation). This is a connected speaker enriched with a 7-chip touch screen. It has a loudspeaker and 3 microphones, making interaction possible.

Google Nest Hub (2e generation) group

The coaching device used is the Gatebox, a hologram like device which the user can interact. There are internal sensors such as a camera and a microphone allow the user to converse with the projected character. It connects to the Internet via a wireless LAN. With infrared rays and Bluetooth, it can also be connected to household appliances and other devices.

Gatebox group

The coaching device used is the CelesTE robot, a prayer companion designed for Christian Catholic users.The intended main function of CelesTE is to be a "guardian angel", especially thought for elderly people. It can be a prayer companion, and contains a vast number of teachings, including the whole Bible. Its AI is capable of keeping a short conversation, in which the user may ask and receive an answer about a sensitive topic (such as happiness, death, faith, etc.). It can also printout a selection of contents. The coaching device CelesTE will be substituted by DarumaTO for the Japanese centers.

CelesTE robot group
bookletOTHER

Participant in the control group will receive a booklet containing information and activities on well-being

Control group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Able to stand and walk unaided;
  • No acute or untreated medical problems;
  • Montreal Cognitive Assessement test (MOCA) ≥ 22;
  • Geriatric Depression Scale (GDS) \< 9;
  • Short performance physical battery (SPPB) ≥ 7
  • Clinical Frailty Scale score between 2 and 4.

You may not qualify if:

  • Use of active implant or not-implant medical devices;
  • Allergy to nichel;
  • A myocardial infarction or stroke within 6 months;
  • Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;
  • Uncontrolled hypertension;
  • Pacemaker or implantable cardioverter defibrillator;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Broca Hospital

Paris, France

Location

Diocesan Caritas Association for the Archdiocese of Cologne

Cologne, Germany

Location

IRCCS INRCA Hospital

Ancona, 60127, Italy

Location

Tohoku University -Smart Ageing Research Center

Miyagi, Japan

Location

Study Officials

  • Roberta Bevilacqua

    IRCCS INRCA, Ancona, Italy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2023

First Posted

April 28, 2023

Study Start

July 24, 2023

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

October 27, 2023

Record last verified: 2023-10

Locations